Covalon Technologies Stock Analysis
| CVALF Stock | USD 2.62 0.14 5.65% |
Covalon Technologies is overvalued with Real Value of 2.17 and Hype Value of 2.62. The main objective of Covalon Technologies otc analysis is to determine its intrinsic value, which is an estimate of what Covalon Technologies is worth, separate from its market price. There are two main types of Covalon Technologies' stock analysis: fundamental analysis and technical analysis.
The Covalon Technologies otc stock is traded in the USA on OTCQX Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Covalon Technologies' ongoing operational relationships across important fundamental and technical indicators.
Covalon |
Covalon OTC Stock Analysis Notes
About 57.0% of the company shares are held by company insiders. The book value of Covalon Technologies was currently reported as 0.96. The company had not issued any dividends in recent years. Covalon Technologies had 1:10 split on the 16th of July 2013. Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. Covalon Tech operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Covalon Technologies is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Covalon Technologies please contact Brian Pedlar at 905 568 8400 or go to https://www.covalon.com.Covalon Technologies Investment Alerts
| The company reported the revenue of 18.15 M. Net Loss for the year was (9.66 M) with profit before overhead, payroll, taxes, and interest of 7.49 M. | |
| Covalon Technologies has accumulated about 14.04 M in cash with (7.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55. | |
| Roughly 57.0% of the company shares are held by company insiders |
Covalon Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Covalon Technologies's market, we take the total number of its shares issued and multiply it by Covalon Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Covalon Profitablity
Covalon Technologies' profitability indicators refer to fundamental financial ratios that showcase Covalon Technologies' ability to generate income relative to its revenue or operating costs. If, let's say, Covalon Technologies is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Covalon Technologies' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Covalon Technologies' profitability requires more research than a typical breakdown of Covalon Technologies' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.5) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.5. Technical Drivers
As of the 2nd of December, Covalon Technologies shows the Mean Deviation of 2.01, downside deviation of 2.64, and Risk Adjusted Performance of 0.0627. Covalon Technologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Covalon Technologies, which can be compared to its peers. Please confirm Covalon Technologies maximum drawdown, as well as the relationship between the downside variance and skewness to decide if Covalon Technologies is priced correctly, providing market reflects its regular price of 2.62 per share. Please also double-check Covalon Technologies total risk alpha, which is currently at (0.27) to validate the company can sustain itself at a future point.Covalon Technologies Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Covalon Technologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Covalon Technologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Covalon Technologies Predictive Daily Indicators
Covalon Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Covalon Technologies otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Covalon Technologies Forecast Models
Covalon Technologies' time-series forecasting models are one of many Covalon Technologies' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Covalon Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Covalon OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Covalon Technologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Covalon shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Covalon Technologies. By using and applying Covalon OTC Stock analysis, traders can create a robust methodology for identifying Covalon entry and exit points for their positions.
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. Covalon Tech operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Covalon Technologies to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Complementary Tools for Covalon OTC Stock analysis
When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |